Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 9/20 | 0.40 |
| ▸ | CYP11B1 | P15538 | 7/20 | 0.40 |
| ▸ | KDM5B | Q9UGL1 | 2/20 | 0.37 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.34 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.33 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.32 |
| ▸ | DRD4 | P21917 | 1/20 | 0.31 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.31 |
| ▸ | CDK9 | P50750 | 1/20 | 0.31 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20053992 | 0.87 | CYP11B1 (0.41) | CYP11B2CYP11B1KDM5BLRRK2SSTR4 | |
| SCHEMBL14701579 | 0.87 | CYP11B1 (0.41) | CYP11B2CYP11B1KDM5BLRRK2SSTR4 | |
| SCHEMBL902531 | 0.81 | KDM5B (0.41) | CYP11B2CYP11B1KDM5BLRRK2SSTR4 | |
| SCHEMBL23109057 | 0.80 | KDM5B (0.41) | CYP11B2CYP11B1KDM5BLRRK2SSTR4 | |
| SCHEMBL22019786 | 0.76 | DRD4 (0.36) | CYP11B2CYP11B1KDM5BLRRK2SSTR4 | |
| SCHEMBL14957659 | 0.73 | CYP11B1 (0.41) | CYP11B2CYP11B1KDM5BLRRK2SSTR4 | |
| SCHEMBL13684190 | 0.72 | — | — | |
| Iodide SCHEMBL7949138 | 0.72 | KDM5B (0.32) | KDM5BSSTR4DRD4DRD3 | |
| SCHEMBL16814051 | 0.69 | NTRK1 (0.40) | CYP11B2CYP11B1SSTR4NTRK1DRD4 | |
| SCHEMBL20074301 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3080103-B1 | BIARYL COMPOUNDS USEFUL FOR THE TREATMENT OF HUMAN DISEASES IN ONCOLOGY, NEUROLOGY AND IMMUNOLOGY | BIOGEN MA INC (US) | 2018-04-18 | — | — | EP | disclosed |